SoniVie
Latest round
- Series C
Last raised
- Jan 2023
Total raised
- $60M
Investors
- 4
About SoniVie
Based in Rehovot, Israel, and founded in 2014, SoniVie Ltd. operates as a medical device company. In January 2023, SoniVie Inc. As of 2022, the company’s CEO is Tomaso Zambelli. SoniVie provides TIVUS (therapeutic intra-vascular ultrasound system), which is a medical device that works on catheter-based technology that was developed for the treatment of pulmonary artery hypertension (PAH). People with chronic obstructive pulmonary disease (COPD) and patients with resistant hypertension are among the groups of patients who utilize the company’s medical device.
Who invested in SoniVie
4 investors across 1 round
See all investors in SoniVie
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 9, 2023
Amount
$60M
Investors
Questions about SoniVie
Who invested in SoniVie?
SoniVie has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SoniVie raised?
SoniVie has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SoniVie last raise money?
SoniVie's most recent round on record is a Series C, in Jan 2023.
What does SoniVie do?
Based in Rehovot, Israel, and founded in 2014, SoniVie Ltd.
Where is SoniVie headquartered?
SoniVie is headquartered in Rehovot, Israel.
Which VCs invest in companies like SoniVie?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at SoniVie's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like SoniVie? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.